extreme pain; nerve damage in arm and shoulder; thinks she's "having extreme inflammation; numbness; menstrual cycle changes.; numb and feeling tingly; shooting pain in her lower arm; Her shoulder blade hurts; swollen lymph nodes; headache; except for the fatigue; she had uterine pain; her breasts hurt; she was having hot flashes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 38 year-old female patient received bnt162b2 (COMIRNATY), administered in arm right, administration date 11Sep2021 09:00 (Lot number: FF2588) at the age of 38 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 07Oct2021, outcome "not recovered", described as "swollen lymph nodes"; PAIN (non-serious), outcome "unknown", described as "extreme pain"; NERVE INJURY (non-serious), outcome "unknown", described as "nerve damage in arm and shoulder"; INFLAMMATION (non-serious), outcome "unknown", described as "thinks she's "having extreme inflammation"; PARAESTHESIA (non-serious) with onset 14Oct2021, outcome "not recovered", described as "numb and feeling tingly"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "numbness"; FATIGUE (non-serious) with onset 11Sep2021, outcome "recovered" (13Sep2021), described as "except for the fatigue"; HEADACHE (non-serious) with onset 12Sep2021, outcome "not recovered", described as "headache"; MENSTRUAL DISORDER (non-serious), outcome "unknown", described as "menstrual cycle changes."; PAIN IN EXTREMITY (non-serious) with onset 13Oct2021, outcome "not recovered", described as "shooting pain in her lower arm"; ARTHRALGIA (non-serious) with onset 12Oct2021, outcome "not recovered", described as "Her shoulder blade hurts"; UTERINE PAIN (non-serious) with onset 2021, outcome "unknown", described as "she had uterine pain"; BREAST PAIN (non-serious) with onset 2021, outcome "unknown", described as "her breasts hurt"; HOT FLUSH (non-serious) with onset 2021, outcome "unknown", described as "she was having hot flashes". The action taken for bnt162b2 was unknown.  Additional Information: Patient is a consumer that was calling about the Covid-19 Vaccine and said that she wanted to report a adverse event that she was having. She had a regret about getting the vaccine. Patient said that she had natural immunity from infection in Apr2021 and then her first dose of the vaccine was on 11Sep2021. She said that she did not have the second dose since she had natural infection and from what she read she did not need it. She said that she had no side effects for the first 48-72 hours except for the fatigue. About 4 weeks later, she had swollen lymph nodes and menstrual cycle changes. She does not know if it is heightened anxiety or not, but she got a shooting pain in her lower arm that woke her up. Her shoulder blade hurts on the opposite side of where she received her vaccine. She is getting tingling and numbness in her hand on the same side as her shoulder pain. She still feels like she has a temple headache that has been lingering since she had the vaccine. Patient had a telehealth visit this morning with her new doctor. She has actual appointment 03Nov2021. She said that she notified the pharmacy of what happened too. Fatigue started that started that Saturday 11Sep2021 and lasted through Sunday and she felt fine by Monday 13Sep2021. On 07Oct2021, she noticed something was going was going on with her body and stated that she thought it was hormonal, she had uterine pain, her breasts hurt, she was having hot flashes. Her symptoms lasted until the 11Oct2021. She thinks the swollen lymph nodes started on the 07Oct2021, but said that she noticed the extreme pain in her lymph node under her left breast on 12Oct2021. Menstrual Cycle change: She never ovulated this month and has not gotten her period yet for this month. She did have a normal menstrual cycle 2 weeks after her dose. She is anticipating that her period will not be normal this month with everything that happened.  Follow-up attempts are completed. No further information is expected.